Chemoinformaics analysis of (E)-2-Hexenyl isobutyrate
Molecular Weight | 170.252 | nRot | 5 |
Heavy Atom Molecular Weight | 152.108 | nRig | 2 |
Exact Molecular Weight | 170.131 | nRing | 0 |
Solubility: LogS | -3.139 | nHRing | 0 |
Solubility: LogP | 3.137 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 30.3063 |
nHD | 0 | BPOL | 20.6617 |
QED | 0.468 |
Synth | 2.459 |
Natural Product Likeliness | 1.099 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.004 |
CACO-2 | -4.239 |
MDCK | 0.0000296 |
BBB | 0.982 |
PPB | 0.745984 |
VDSS | 1.46 |
FU | 0.323833 |
CYP1A2-inh | 0.918 |
CYP1A2-sub | 0.399 |
CYP2c19-inh | 0.323 |
CYP2c19-sub | 0.803 |
CYP2c9-inh | 0.14 |
CYP2c9-sub | 0.859 |
CYP2d6-inh | 0.048 |
CYP2d6-sub | 0.593 |
CYP3a4-inh | 0.065 |
CYP3a4-sub | 0.216 |
CL | 6.174 |
T12 | 0.869 |
hERG | 0.022 |
Ames | 0.006 |
ROA | 0.033 |
SkinSen | 0.599 |
Carcinogencity | 0.26 |
EI | 0.973 |
Respiratory | 0.106 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.935674 |